Synvista Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 17.8yrs |
Recent management updates
No updates
Recent updates
No updates
CEO
Synvista Therapeutics has no CEO, or we have no data on them.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Director | 18.3yrs | US$89.14k | no data | |
Medical & Clinical Advisor | no data | no data | no data | |
Director | 18.3yrs | US$445.08k | no data | |
Independent Director | 17.2yrs | US$70.02k | no data | |
Medical & Clinical Advisor | no data | no data | no data | |
Medical & Clinical Advisor | no data | no data | no data | |
Medical & Clinical Advisor | no data | no data | no data | |
Medical & Clinical Advisor | no data | no data | no data | |
Medical & Clinical Advisor | no data | no data | no data | |
Director | 16.1yrs | no data | no data |
17.8yrs
Average Tenure
71yo
Average Age
Experienced Board: SYNI's board of directors are seasoned and experienced ( 17.8 years average tenure).